Cencora, INC 8-K filings

Richard W. Gochnauer and Kathleen W. Hyle will retire from Cencora's Board of Directors at the Annual Meeting of Stockholders on March 6, 2025.

Cencora has completed its acquisition of Retina Consultants of America and raised its adjusted diluted EPS guidance for fiscal year 2025.

Cencora, Inc. has successfully completed a $1.8 billion senior notes offering to finance the acquisition of Retina Consultants of America and for general corporate purposes.

Cencora has successfully priced $1.8 billion in senior notes across three tranches to finance the acquisition of Retina Consultants of America and for general corporate purposes.

Cencora, Inc. has entered into a $1.5 billion term loan and a $1.0 billion revolving credit facility to support its acquisition of Retina Consultants of America.

Cencora has announced a definitive agreement to acquire Retina Consultants of America (RCA) for approximately $4.6 billion, aiming to enhance its specialty leadership and MSO solutions.

Cencora's Q4 2024 revenue reached $79.1 billion, a 14.7% year-over-year increase, with adjusted diluted EPS of $3.34, and the company also announced an 8% increase in its quarterly dividend.

Cencora, Inc. has amended its revolving credit facility and trade receivables securitization facility, extending the maturity dates and modifying certain terms.

Cencora has increased its adjusted diluted EPS guidance for fiscal year 2024 but anticipates growth to be at the lower end of its long-term targets for fiscal year 2025 due to COVID-related headwinds and a potential customer loss.

Cencora, Inc. has updated its bylaws, established new indemnification and employment agreements, and amended its shareholder agreement with Walgreens Boots Alliance.

Cencora has appointed Frank Clyburn as an independent director, effective October 1, 2024, increasing the board size to thirteen members.

Cencora, Inc. has repurchased approximately $250 million of its common stock from Walgreens Boots Alliance Holdings LLC as part of a larger share sale by the latter.

Cencora, Inc. reported a data exfiltration incident where personal and health information was compromised, but the company believes it has contained the incident and does not expect a material impact on its financials.

Cencora's third-quarter revenue increased by 10.9% year-over-year to $74.2 billion, leading to an increase in adjusted diluted EPS and an updated full-year outlook.

Cencora has repurchased approximately $400 million of its common stock from Walgreens Boots Alliance Holdings LLC and raised its fiscal year 2024 adjusted diluted earnings per share guidance.

Cencora's Executive Vice President and Chief Communications & Administrative Officer, Gina K. Clark, has announced her retirement, effective September 30, 2024.

Cencora's second quarter revenue increased by 7.8% year-over-year to $68.4 billion, with adjusted diluted EPS rising 8.6% to $3.80, leading to an increased full-year adjusted EPS guidance range.

Cencora, Inc. has amended its securitization facility, extending the termination date to October 21, 2026, and adding new committed purchasers.

Cencora, Inc. has disclosed the compensation arrangements for its outgoing CEO, Steven H. Collis, as he transitions to Executive Chairman, and for incoming CEO, Robert P. Mauch.

Cencora's shareholders approved amendments to the company's certificate of incorporation, including officer exculpation, at the 2024 Annual Meeting.

Cencora has announced that Robert P. Mauch will succeed Steven H. Collis as CEO, effective October 1, 2024, with Collis transitioning to Executive Chairman.

Cencora, Inc. reported a data exfiltration incident from its information systems, some of which may contain personal information, and has launched an investigation.

Cencora, Inc. has repurchased approximately $50 million of its common stock from Walgreens Boots Alliance Holdings LLC as part of a larger share sale by the latter.

Cencora, Inc. has successfully completed a $500 million offering of senior notes due 2034, with the primary intention of redeeming its 2024 senior notes.

Cencora has announced the pricing of a $500 million senior notes offering to redeem existing debt and for general corporate purposes.

Cencora's first quarter fiscal 2024 results show a 15% year-over-year revenue increase to $72.3 billion and an adjusted diluted EPS of $3.28, leading to an increased full-year guidance.

Cencora's director, Henry W. McGee, will retire at the 2024 Annual Meeting, reducing the board size from 12 to 11 members.